In another observational study involving 947 patients with CHC without a history of HCC treated with DAAs conducted in Japan, Nakagawa et al. showed that higher levels of Mac-2 binding protein glycosylation isomer cutoff indices (a serological liver fibrosis marker) at SVR were used to predict worse overall survival [37]. Here, LGALS3BP is linked to hepatocellular carcinoma.